6 Publications
2012
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.
Duke, Jon DHan, XuWang, ZhipingSubhadarshini, AbhinitaKarnik, Shreyas DLi, XiaochunHall, Stephen DJin, YanCallaghan, J TOverhage, Marcus JFlockhart, David AStrother, R MQuinney, Sara K and Li, Lang
PLoS computational biology, vol. 8, (no. 8), pp. e1002614, 2012. | Journal Article
2009
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy
Onitilo, Adedayo AMc Carty, Catherine AWilke, RussellGlurich, IngridEngel, Jessica MFlockhart, David ANguyen, AnneLi, LangMi, DemingSkaar, Todd and Jin, Yan
Breast cancer research and treatment., vol. 115, (no. 3), pp. 643-650, 2009. | Journal Article
2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Jin, YanJin, YanJin, YanHayes, DanielHayes, Daniel FHayes, DanielLi, LangLi, LangLi, LangRobarge, Jason DRobarge, JasonRobarge, JasonSkaar, Todd CSkaar, ToddSkaar, ToddPhilips, SantoshPhilips, SantoshPhilips, SantoshNguyen, AnneNguyen, AnneNguyen, AnneSchott, AnneSchott, AnneSchott, AnneHayden, JillHayden, JillHayden, JillLemler, SuzanneLemler, SuzanneLemler, SuzanneStorniolo, AnnaStorniolo, AnnaStorniolo, Anna MFlockhart, DavidFlockhart, DavidFlockhart, David AStearns, VeredStearns, Vered and Stearns, Vered
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 36), pp. 5849-54, 2008/Dec/20. | Journal Article
2006
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.
Borges, SilvanaDesta, ZeruesenayLi, LangSkaar, Todd CWard, Bryan ANguyen, AnneJin, YanStorniolo, Anna MNikoloff, D MWu, LinHillman, GrantHayes, Daniel FStearns, Vered and Flockhart, David A
Clinical pharmacology and therapeutics, vol. 80, (no. 1), pp. 61-74, 2006/Jul. | Journal Article
2005
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Jin, YanDesta, ZeruesenayStearns, VeredWard, BryanHo, HerbertLee, Kyung-HoonSkaar, Todd CStorniolo, Anna MLi, LangAraba, AdjeiBlanchard, RebeccaNguyen, AnneUllmer, LyndaHayden, JillLemler, SuzanneWeinshilboum, Richard MRae, JamesHayes, Daniel F and Flockhart, David A
Journal of the National Cancer Institute, vol. 97, (no. 1), pp. 30-9, 2005/Jan/5. | Journal Article
 
The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.
Vitseva, OlgaFlockhart, David AJin, YanVarghese, Sonia and Freedman, Jane
The Journal of pharmacology and experimental therapeutics, vol. 312, (no. 3), pp. 1144-50, 2005/Mar. | Journal Article